Background Increasingly, patient medication adherence data are being consolidated from
claims databases and electronic health records (EHRs). Such databases offer an indirect …

Purpose Older women (≥ 70 years old) with breast cancer undergo different treatments than
young women. Studies have examined factors that influence this disparity, but synthesized …

Aim The objectives are to compare responses of breast cancer (BCa) treatment groups
(chemotherapy, tamoxifen, and aromatase inhibitors (AIs) to each other and a control …

Background: Initiating treatment within the optimal time is critical for women with breast
cancer. A delay in cancer treatment initiation can result in increased morbidity and mortality …

Background In breast cancer patients, adherence to adjuvant hormone therapy (AHT) is
uncertain. Seven in every 10 patients were hormone receptor positive and adjuvant …

PURPOSE Adherence to tamoxifen citrate among women diagnosed with metastatic breast
cancer can improve survival and minimize recurrence. This study aimed to use real-world …

PURPOSE Ductal carcinoma in situ (DCIS) accounts for 20% of breast cancer cases in the
United States and is potentially overtreated, leading to high expenditures and low-value …

The evolution of ductal carcinoma in situ (DCIS) management has been driven by a parallel
evolution in our understanding of its natural history. Early trials established the benefit of …

Tamoxifen, a cornerstone in the adjuvant treatment of estrogen receptor-positive breast
cancer, significantly reduces breast cancer recurrence and breast cancer mortality; however …

Objectives The objective of this study was to evaluate patient compliance with management
recommendations given by a breast cancer multidisciplinary team (MDT), assess for reasons …